fda ind, page-33

mudpecker, I agree with your sentiment. BLT does have a bright future if management take note of the lesson that is playing out right now.

We have a good announcement today but the sp has gone nowhere. Why? Because the run to 75c was when the enthusiasm for the IND took off but the delay in filing the application in the timeframes mentioned by the company has seen that enthusiasm stagnate. (I am still off the opinion that the sp could have been stabilized at that level if the Calimmune CIRM and CoH HIV information had been announced by BLT.)

Today's announcement means that the trial will start and so I don't expect the first patient dosed announcement will make a significant impact on the sp because the market is factoring that into the current sp. It will take good results and the announcement of a deal or a Tacere IPO to make the sp take off. I hope that we can line up these two things.